Peak Financial Advisors LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Peak Financial Advisors LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, Holdings Channel.com reports. The fund acquired 3,738 shares of the company’s stock, valued at approximately $1,122,000.

Other hedge funds have also made changes to their positions in the company. MML Investors Services LLC increased its stake in shares of HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after acquiring an additional 4,285 shares during the period. Meritage Group LP acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $150,548,000. Alpha DNA Investment Management LLC acquired a new position in HCA Healthcare during the third quarter worth $869,000. NRI Wealth Management LC acquired a new stake in HCA Healthcare in the fourth quarter valued at $2,896,000. Finally, Czech National Bank increased its holdings in shares of HCA Healthcare by 4.5% in the 4th quarter. Czech National Bank now owns 39,543 shares of the company’s stock valued at $11,869,000 after purchasing an additional 1,691 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $400.00 to $320.00 in a report on Monday, November 25th. Oppenheimer increased their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Finally, TD Cowen reduced their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $385.27.

HCA Healthcare Stock Down 0.8 %

HCA opened at $305.63 on Wednesday. The business has a 50-day moving average of $319.34 and a two-hundred day moving average of $353.44. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 12 month low of $276.50 and a 12 month high of $417.14. The stock has a market capitalization of $77.42 billion, a price-to-earnings ratio of 13.72, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were issued a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.86%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.